dokumendiregister.ee
OtsingAsutusedMCP
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Regional workshop

Sotsiaalministeerium · 18. november 2019
Viit
1.4-4/2809-1
Registreeritud
18. november 2019
Dokumendi liik
Sissetulev kiri
Adressaat
EURO HIV
Saabumis/saatmisviis
e-post
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-4 Kutsed ja kirjavahetus rahvusvahelistel seminaridel, konverentsidel jt üritustel osalemiseks
Toimik
1.4-4/2019
Vastutaja
Liisa Lents (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Euroopa Liidu ja väliskoostöö osakond)
Lahendamise tähtaeg
18. detsember 2019

Failid

  • 📎E-kiri.pdf69 KB
  • 📎ENG Scope and purpose_Implementation research workshop_for translation.pdf84 KB
  • 📎EST IS workshop nomination letter ENG.pdf87 KB

Sisu (failidest)

WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTÉ REGIONAL OFFICE FOR EUROPE BUREAU RÉGIONAL DE L'EUROPE WELTGESUNDHEITSORGANISATION ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ REGIONALBÜRO FÜR EUROPA ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО Regional workshop on advancing /2 implementation science on HIV and viral hepatitis in eastern Europe and Central Asia Berlin, Germany 15 November 2019 10-11 February 2020 Original: English Scope and purpose Background The WHO Region for Europe has an estimated 2.5 million people living with HIV, including 1.7 million in eastern Europe and central Asia (EECA)1. Each year new HIV diagnoses continue to rise. In 2017, there were about 160 000 new HIV diagnoses of whom more than 80% originated from EECA2. Despite evidence that key populations are major drivers of the epidemic in most countries, comprehensive preventive measures, including harm reduction programmes for people who inject drugs and combination prevention programmes for men who have sex with men and other key and bridging populations are inadequate. In addition, there is a need to scale up implementation of the latest WHO recommendations and address services delivery barriers throughout the continuum of care, from testing to treatment in order to improve the persistent gap toward the 90-90-90 cascade targets (which stood at 82%-66%-84% for the Region and 72%-54%-77% in EECA as of 2018). The Region is also home to an estimated 14 million people with chronic hepatitis C (HCV). It is estimated that 31% of those who are infected with HCV are diagnosed and only 5% of those diagnosed started on treatment. About 15 million people are estimated to have chronic hepatitis B among whom only 13% are diagnosed. Countries of the Region have developed national action plans to address viral hepatitis and strategies and service delivery models to diagnose and treat people with chronic hepatitis are being developed. Vulnerable groups often have overlapping HIV-hepatitis and TB risks and co- morbidities to be addressed in an integrated manner. Inadequate At this juncture of the HIV and hepatitis response, there is an increasing need for generating and using scientific and programmatic evidence on how to optimize the practical implementation of evidence-based policies and recommendations in diverse real-world social, cultural, economic and health-system settings. Investigating and addressing barriers that limit program quality, efficiency and effectiveness, or testing and determining which alternative service delivery strategy would yield most impact, are central themes of implementation science and key to elimination. Against this background, a regional workshop on “advancing implementation science on HIV and viral hepatitis in the WHO European region” will be held on 10-11 February 2020 in Berlin, Germany. Overall purpose of the event 1 UNAIDS. AIDSinfo database (https://aidsinfo.unaids.org/). 2 ECDC/WHO. HIV/AIDS Surveillance in Europe 2018 – 2017 data. Copenhagen: WHO Regional Office for Europe; 2018. Scope and purpose page 2 The workshop aims at supporting the participants in conducting and using implementation science and programme data to guide the practical implementation of WHO recommendations within their HIV, viral hepatitis and integrated TB/HIV/viral Hepatitis programmes. It also aims at fostering collaboration between academics, scientists, funders and partners to conduct and support implementation science. Objectives 1. To share relevant examples of HIV, viral hepatitis and integrated TB/HIV/Viral Hepatitis implementation science and how their findings have been used for decision making and programme improvement; 2. To improve capacity to use programme data as well as generating and using scientific evidence from HIV, hepatitis and TB/HIV/Viral Hepatitis implementation science to improve the efficiency of national programmes; 3. To propose a draft HIV and Viral Hepatitis implementation research agenda for eastern Europe and central Asia. Expected results and outputs • Overview of the extent to which implementation science is being conducted and used in the countries of eastern Europe and central Asia. • Agreed way forward and next steps for developing an implementation research agenda, including options for strengthened collaboration between researchers across the Region. • Meeting report prepared by the WHO Regional Office for Europe and published online. Event Format The workshop will be organized in collaboration with the Robert Koch Institute (RKI), and will be held in Berlin, Germany on 10-11 February 2020. The meeting is envisaged as a regional workshop with a mix of plenary sessions and working sessions on defined topics. In addition to WHO and its Collaborating Centre representatives, speakers will include researchers from across the WHO European Region who have led relevant examples of implementation science and data use leading to programme improvement. Participants The workshop will bring together EECA country representatives alongside academics, experts, clinicians, communities, partners and donors from across the WHO European Region. Specifically, participants will include: • A team of three representatives from 15 countries3 which include two nominated country participants (one person responsible for HIV surveillance and research and one HIV or hepatitis treatment expert or national programme manager) as well as civil society representatives, preferably all with experience in research. • Representatives of academic institutions, WHO Collaborating Centres, researchers, invited experts and speakers, partner agencies and donors. • Representatives from WHO Regional Office for Europe, country offices and headquarters. 3 Armenia, Azerbaijan, Belarus, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Republic of Moldova, Russian Federation, Tajikistan, Turkmenistan, Ukraine and Uzbekistan. Saatja: EURO HIV <[email protected]> Saadetud: 18.11.2019 13:01 Adressaat: Elen Ohov <[email protected]> Koopia: SM Info <[email protected]>; <[email protected]>; <[email protected]>; REINAP, Marge <[email protected]>; REINAP, Marge <[email protected]>; SEGUY, Nicole Simone <[email protected]>; STENGAARD, Annemarie <[email protected]>; RUNDSTROEM, Maria <[email protected]>; ROMERO, Adriana Natalia <[email protected]> Teema: Regional workshop on advancing implementation science on HIV and viral hepatitis in eastern Europe and central Asia Berlin, Germany, 10-11 February 2020 Dear Ms Ohov, For your kind perusal, we are pleased to enclosed herewith request for nomination letter concerning upcoming Regional workshop on advancing implementation science on HIV and viral hepatitis in eastern Europe and central Asia Berlin, Germany, 10-11 February 2020. We would highly appreciate receiving nomination from your country by 18 December 2019 in order to arrange necessary logistic for the participants on time. With kind regards, JTH Team WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTÉ WELTGESUNDHEITSORGANISATION Date: 18 November 2019 ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ REGIONAL OFFICE FOR EUROPE Ms Elen Ohov BUREAU RÉGIONAL DE L’EUROPE REGIONALBÜRO FÜR EUROPA Adviser ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО European Union Affairs and International Co- Head office: operation Department UN City, Marmorvej 51, Ministry of Social Affairs DK-2100 Copenhagen Ø, Denmark Suur-Ameerika 1 Tel.: +45 45 33 70 00; Fax: +45 45 33 70 01 Email: [email protected] Tallinn 10122 Website: http://www.euro.who.int Estonia Email: [email protected] Our reference: JTH Your reference: Notre référence: ANB/ Votre référence: Unser Zeichen: Ihr Zeichen: См. наш номер: На Ваш номер: Dear Ms Ohov, Regional workshop on advancing implementation science on HIV and viral hepatitis in eastern Europe and central Asia Berlin, Germany, 10-11 February 2020 I have the honour to inform you that the World Health Organization Regional Office for Europe (WHO/Europe) in collaboration with the Robert Koch Institute is convening the above-mentioned workshop in Berlin, Germany on 10-11 February 2020. Global strategies and regional and national action plans on the health sector response to HIV and Viral Hepatitis are in place, however, there is an increasing need for generating and using scientific and programmatic evidence on how to optimize the practical implementation of WHO recommendations taking into account the social, cultural, economic and health-system settings. The workshop aims at strengthening the use of implementation science and programme data to improve the efficiency of national HIV and Viral Hepatitis programmes, fostering further collaboration between national and international partners and researches and proposing a draft HIV and Viral Hepatitis implementation research agenda for eastern Europe and central Asia (EECA). The specific workshop objectives are described in the enclosed scope and purpose. It is my pleasure to invite you to nominate two participants to attend this event: • A technical expert with strong experience in HIV surveillance, analysis and research. • A senior national staff with responsibility for the overall practical implementation of HIV and/or Viral Hepatitis prevention, testing and treatment activities in your country, preferably with experience in implementation research. In addition, WHO/Europe will invite representatives from civil society to join the respective country teams, aiming to facilitate strong collaboration between the government and civil sectors for defining and strengthening an implementation research agenda and practical next steps. UN City, Marmorvej 51 Tel.: +45 45 33 70 00 Email: [email protected] DK-2100 Copenhagen Ø Fax: +45 45 33 70 01 Website: http://www.euro.who.int Denmark The working language will be English and simultaneous Russian interpretation will be provided. Travel and accommodation for participants will be arranged and paid for by this office in accordance with our travel regulations. I look forward to receiving your nominations, giving the names, functional titles and addresses of the proposed participants at your earliest convenience and no later than Wednesday 18 December 2019. We shall then communicate with the nominees directly and provide the necessary documentation and administrative information. For further queries, please contact Dr Nicole Seguy, HIV/viral hepatitis Unit Lead ([email protected] with a copy to [email protected]). Yours sincerely, Dr Masoud Dara Coordinator, Communicable Diseases Department Division of Health Emergencies and Communicable Diseases WHO Regional Office for Europe Enclosures: Scope and Purpose Copy for information: Ms Triin Uusberg, Head, European and International Coordination Department, Ministry of Social Affairs, Suur- Ameerika 1, Tallinn 10129, Estonia Email: [email protected], [email protected] H.E. Ms Katrin Saarsalu-Layachi, Ambassador Extraordinary and Plenipotentiary, Permanent Representative, Permanent Mission of the Republic of Estonia to the United Nations Office and other international organizations in Geneva, Chemin du Petit-Saconnex 28A, Genève CH-1209, Switzerland Email: [email protected] H.E. Mr Märt Volmer, Ambassador Extraordinary and Plenipotentiary, Embassy of the Republic of Estonia, Frederiksgade 19, 4th floor, Copenhagen K 1265, Denmark Email: [email protected] Ms Marge Reinap, Head of WHO Office, WHO Country Office, Estonia, Paldiski Road 81, Tallinn 10617, Estonia, Email: [email protected], [email protected] –2–
Allikas: Sotsiaalministeerium dokumendiregister →